Ryan R. Friess

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells”.

Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-008959

N/A

0DataRank · unranked

11 citations

Rob H. Hullsiek, Kate Dixon, Sam C. Wang, Anders Lindstedt, Ryan R. Friess +8 more

Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.05.09.593347

N/A

0DataRank · unranked

1 citations

Rob H. Hullsiek, Kate Dixon, Sam C. Wang, Anders Lindstedt, Ryan R. Friess +8 more

Targeted ADAM17 blocker directed to CD16 (TAB16) augments NK cell proliferation and cytotoxicity 3752

The Journal of Immunology(2025)10.1093/jimmun/vkaf283.1517

N/A

0DataRank · unranked

0 citations

Robert Hullsiek, Ryan R. Friess, Anders W. Matson, Sam C. Wang, Jianming Wu +5 more